Company Filing History:
Years Active: 1999-2003
Title: Vincent Peter Schulz: Innovator in Protein Complexes and Disease Treatment
Introduction
Vincent Peter Schulz is a notable inventor based in Madison, Connecticut, with a significant contribution to the field of protein complexes and their applications in treating various diseases. He holds a total of six patents, showcasing his innovative approach to scientific research and development.
Latest Patents
Among his latest patents, Schulz has developed complexes of the 53BP2 protein, which interact with several other proteins identified through a yeast two-hybrid assay system. These proteins include β-tubulin, p62, hnRNP G, and three gene products, 53BP2-IP1, 53BP2-IP2, and 53BP2-IP3. His invention not only provides these complexes but also includes methods for screening their efficacy in treating and preventing diseases such as cancer, autoimmune diseases, and neurodegenerative disorders. Another significant patent involves the CDK2 protein, which interacts with proteins like cyclin H, cyclin I, and ERH, as well as splice variants hsReq*-1 and hsReq*-2. This invention also aims to screen for efficacy in treating similar diseases.
Career Highlights
Schulz has worked with prominent companies in the biotechnology sector, including Curagen Corporation and Genaissance Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in protein interactions and their implications in health.
Collaborations
Throughout his career, Schulz has collaborated with notable colleagues such as Krishnan Nandabalan and Meijia Yang, enhancing his research through teamwork and shared knowledge.
Conclusion
Vincent Peter Schulz's innovative work in protein complexes and their applications in disease treatment highlights his significant contributions to science and medicine. His patents reflect a commitment to advancing healthcare solutions through research and collaboration.